HCPCS Code S0161: Calcitriol 0.25 mcg billing reference

HCPCS Code S0161 is a deleted HCPCS Level II S-code for calcitriol 0.25 mcg. Calcitriol is the active form of vitamin D used in dialysis and renal care. CMS deleted S0161 effective October 1, 2010 and cross-references it to S0169, “Calcitrol, 0.25 microgram”, which carries the same drug at the same strength.

Injectable calcitriol is a separate code, J0636. Any claim submitted with S0161 today is rejected at the payer level before clinical review. A superbill template that still carries it needs the replacement loaded in its place.

Found our content helpful?

Key takeaways

HCPCS Code S0161 described calcitriol 0.25 mcg and was deleted from the HCPCS Level II code set effective October 1, 2010

S0169 (Calcitrol, 0.25 microgram) is the direct one-to-one replacement CMS points billers to in place of S0161

Injectable calcitriol is billed with J0636 (injection, calcitriol, 0.1 mcg), a permanent code for a different route and a different unit

S0169 sits in the non-Medicare S-code range, so commercial and Medicaid plans set their own coverage and some ask for J3490 with an invoice instead

Practice management software like Pabau flags deleted and inactive codes before submission, so rejections get caught before the claim leaves the practice

HCPCS Code S0161: Definition and official details

HCPCS Code S0161 was the HCPCS Level II descriptor for calcitriol at the 0.25 mcg strength. It sat in the temporary national S-code range maintained by the Centers for Medicare and Medicaid Services (CMS). The official CMS descriptor read “Calcitrol, 0.25 mg”.

Its replacement, S0169, states the strength as 0.25 microgram, which matches the dispensed oral product. S-codes cover drugs and services that have no permanent code in CPT or in the permanent Level II ranges.

The table below summarizes the core code data for S0161 before deletion, plus the code that took its place.

The history still matters at practices that treat renal or dialysis patients. Many of them carry legacy code sets from earlier fiscal years. An outdated superbill template referencing S0161 produces a rejection the moment the claim reaches the clearinghouse or payer.

Is S0161 still active or has it been deleted?

HCPCS Code S0161 is deleted and cannot be used for billing. It was terminated effective October 1, 2010. The AAPC coding database and the CMS HCPCS Level II annual code files both list S0169 as the code to use instead.

Submitting a claim with a deleted HCPCS code triggers an automatic rejection at adjudication. Payers do not evaluate the clinical documentation when the code itself is invalid.

There is no grace period. CMS and commercial payers treat deleted codes the same way, so the claim fails at the front end of adjudication before any medical necessity review. The denial arrives as a technical rejection rather than a clinical one. Resubmission means correcting the code, not the supporting documentation.

Practices running older EHR or billing software with infrequent code set updates are most at risk. A code loaded into a charge capture template during an earlier year can persist unnoticed through multiple billing cycles. A yearly audit of active procedure codes against the current CMS HCPCS file catches those entries before they cost a cycle.

What are HCPCS Level II S-codes?

HCPCS Level II S-codes are temporary national codes used to describe drugs, supplies, and services that the permanent CPT code set does not cover. CMS assigns and maintains S-codes for billing situations where no permanent Level I or Level II code exists. That makes them a flexible but provisional category.

Several characteristics define how S-codes behave in practice:

• Temporary by design: S-codes are issued as stopgaps while a permanent code is developed, or while a drug or service is still gaining clinical adoption. They can be deleted once a permanent code exists or once the service falls out of use.
• Non-Medicare by default: Medicare does not recognize HCPCS Level II S-codes. Commercial payers, Medicaid programs, and managed care organizations each set their own coverage policies for S-codes, which creates wide variation across payers.
• Annual review cycle: CMS publishes HCPCS Level II code updates quarterly, with major additions, deletions, and revisions effective at the start of each calendar year. S-codes are among the most frequently affected.
• No RVU assignment: Unlike CPT codes, S-codes do not carry AMA/CMS relative value unit (RVU) assignments. Payment rates are set entirely by individual payer contracts.

S0161 followed the typical S-code lifecycle. It was issued to address a specific drug billing need, maintained while relevant, then deleted and superseded by a corrected descriptor. The AAPC Codify HCPCS lookup flags S0161 as a deleted code alongside its last-known descriptor.

One point carries over to the replacement. S0169 is also an S-code, so the non-Medicare limitation and the payer-by-payer coverage rules above apply to it too.

What is calcitriol and when is it prescribed?

Calcitriol is 1,25-dihydroxyvitamin D3, the biologically active form of vitamin D produced by the kidneys. Dietary vitamin D and cholecalciferol supplements need renal conversion before they work. Calcitriol does not, which makes it the preferred therapeutic form for patients whose kidneys can no longer perform that conversion.

Clinical prescribing of calcitriol is concentrated in settings where calcium regulation is impaired. The primary indications, according to FDA prescribing information, include:

• Secondary hyperparathyroidism in dialysis patients: Patients on hemodialysis or peritoneal dialysis commonly develop secondary hyperparathyroidism. Their kidneys can no longer activate vitamin D on their own. Calcitriol suppresses parathyroid hormone (PTH) secretion and helps regulate calcium-phosphate balance.
• Hypocalcemia in dialysis patients: End-stage renal disease (ESRD) disrupts calcium homeostasis. Calcitriol is used to correct hypocalcemia when oral supplementation alone is insufficient.
• Hypoparathyroidism: Some patients have parathyroid glands that are absent or non-functional after surgery or autoimmune damage. Calcitriol can substitute for the role parathyroid hormone plays in calcium regulation.
• Vitamin D-dependent rickets: Rare inherited or acquired conditions that impair vitamin D metabolism respond to calcitriol, because the drug bypasses the defective enzymatic steps.

Every administration has to be coded for both the drug and the route. S0161 covered the oral 0.25 mcg capsule formulation while it was active, and S0169 covers it now. Calcitriol given by injection has always billed under a separate code and follows a different payer pathway.

Alternative and related codes after S0161 was deleted

S0169 is the direct replacement for S0161. CMS retired S0161 on October 1, 2010 and cross-references it to S0169. That code describes the same drug at the same 0.25 microgram strength, so the crosswalk is one to one. Two further codes matter, depending on how the calcitriol reaches the patient and which payer is being billed.

Route of administration decides between the first two codes. Oral calcitriol capsules or solution map to S0169 and bill per 0.25 microgram. Calcitriol given by injection maps to J0636 and bills per 0.1 mcg, so the units are not interchangeable.

Because S0169 sits in the non-Medicare S-code range, some commercial plans and Medicaid programs decline it. They ask for J3490 with an invoice instead. Checking the denial codes on the remittance tells you which situation applies, because the reason code separates code validity from coverage policy.

Between the two routes and the payer rules, four codes are in play at once. The chart below shows which one applies in each situation.

Before billing any code listed here, verify its current status. The CMS HCPCS Level II file via PGM Billing and the NLM Clinical Tables HCPCS API both carry it. HCPCS codes are updated annually and coverage policies change. The codes above are the standard alternatives, and they are not billing advice for a specific payer or clinical scenario.

How to bill calcitriol now that S0161 is deleted

The switch from S0161 to S0169 is a code-set maintenance task rather than a clinical one, and it takes six steps to close out properly.

1. Remove S0161 everywhere it is stored: superbill templates, charge-capture screens, favorites lists, and any fee schedule imported from a pre-2011 file.
2. Map by route: the oral 0.25 mcg strength goes to S0169, and injectable calcitriol goes to J0636. Keep the two entries separate, because the billed units differ.
3. Check the payer before the first claim: S0169 is a non-Medicare code, so confirm acceptance on each commercial and Medicaid drug fee schedule.
4. Have a fallback ready: where a payer declines S-codes, bill J3490 instead. Attach an invoice with the drug name, strength, NDC, units dispensed, and acquisition cost.
5. Pair the claim with the right diagnosis: use the ICD-10-CM code that matches the documented condition, not a general vitamin D deficiency code.
6. Settle prior authorization first: start the request before the drug is dispensed rather than after the claim comes back denied.

Associated ICD-10 diagnosis codes

Calcitriol claims require a supporting ICD-10-CM diagnosis code that establishes medical necessity. The diagnosis code has to reflect the condition being treated rather than defaulting to vitamin D deficiency.

The table below lists ICD-10-CM codes commonly paired with calcitriol billing. Verify each one against the current-year CMS ICD-10-CM code file before use.

Payers reviewing medical necessity for calcitriol claims will check the ICD-10-CM code against the FDA-approved indications. That review is tightest on oral claims routed through an unclassified code. Code to the highest level of specificity the chart documents. Choosing N25.81 over E55.9 cuts the risk of a medical necessity denial.

Billing and coverage guidance for calcitriol

Coverage for calcitriol varies by payer type and clinical setting, and the replacement code inherits that variation from S0161. The framework below reflects general industry guidance. Individual payer contracts and local coverage determinations (LCDs) always take precedence over general rules.

Medicare coverage for calcitriol

Medicare does not recognize HCPCS Level II S-codes, so neither S0161 nor its replacement S0169 was ever billable to Medicare. For dialysis patients, calcitriol given intravenously as part of ESRD treatment falls under the Medicare ESRD bundled payment system (ESRD PPS).

It is paid inside the facility’s per-treatment rate rather than billed separately under J0636. Oral calcitriol for ESRD patients may instead be covered under Medicare Part D, the prescription drug benefit, rather than Part B.

Commercial and Medicaid payer coverage

Commercial insurers and state Medicaid programs decide for themselves whether they accept S0169. The plans that do treat it as the straight successor to S0161 and price it from the contract. Where a plan declines S-codes, practices bill oral calcitriol through J3490 instead.

The claim needs an itemized invoice listing the drug name, strength, National Drug Code (NDC), units dispensed, and wholesale acquisition cost. Without that documentation, the unclassified drug claim denies. A standing checklist for unclassified drug submissions keeps the paperwork consistent across every claim.

Prior authorization is common for calcitriol, particularly for the oral formulation billed to commercial payers. Verifying coverage at the time of prescription beats doing it at claim submission. That avoids the most common delay, where the prior auth requirement surfaces only after the claim comes back denied.

Add a field to your superbill that flags drug claims needing prior authorization. Front-desk and billing staff can then start the process before the drug is dispensed.

How Pabau supports accurate HCPCS billing

Managing HCPCS code changes across an annual update cycle is one of the quieter operational risks in a busy practice. A deleted code like S0161 sitting in a billing template can generate rejections for months before anyone connects the pattern to a code status issue.

Pabau, practice management software for clinical and billing teams, catches that at entry instead. It runs claims management that validates every line against the current HCPCS set before submission.

Practices using Pabau for billing workflows get pre-submission claim validation that checks code combinations, flags missing documentation, and routes claims through a structured review. Drug code billing makes that matter more than usual. An S0169 line can be refused by one payer and accepted by the next, and a J3490 line needs an attached invoice and NDC.

Holding the billing record and the clinical documentation on one platform changes that. The billing team has the supporting information at claim time instead of chasing it across disconnected systems.

Practices managing renal care, dialysis referral billing, or IV therapy involving vitamin D analogs can run all of it in one place. Pabau standardizes drug billing workflows, keeps code sets current, and cuts the overhead of annual HCPCS updates.

Stop catching deleted-code rejections after the fact

Pabau’s claims workflow validates HCPCS codes before submission, flags missing documentation on drug claims, and keeps your billing team ahead of annual code updates. See how it works for your practice.

Book a demo

Conclusion

S0161 has been dead for more than a decade, so what remains is maintenance rather than coding judgment. Pull it out of every superbill, charge-capture screen, and imported fee schedule, then load S0169 and J0636 in its place.

Route decides the code, and the payer decides whether the S-code is accepted at all. Confirm both on each commercial and Medicaid drug fee schedule before the first claim of the year. A practice that settles it in January stops paying for it one rejection at a time.

Pabau’s billing tools validate code combinations before claims leave the system, which lowers the cost of catch-and-correct billing cycles. If your team manages drug billing alongside a broader practice workflow, book a demo. We will walk through how the code checks fit your setup.

Continue your research

Need to understand how drug claim denials get resolved? Denial management in healthcare covers the structured approach to identifying, appealing, and preventing claim denials across drug and procedure codes.

Looking for a structured overview of HCPCS billing requirements? Superbill documentation guide explains what a compliant superbill must contain for drug and procedure billing, including unclassified drug code requirements.

Want to see how prior authorization fits into the billing workflow? Insurance eligibility verification outlines when and how to check coverage before prescribing or dispensing a drug.

Frequently asked questions